Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2021
Jun 30, 2020
Jun 30, 2019
Jun 30, 2018
Total Revenue
478,778
545,744
655,407
684,563
Cost of Revenue
403,185
380,524
411,797
395,857
Gross Profit
75,593
165,220
243,610
288,706
Operating Expenses
Research Development
24,173
29,978
38,807
29,196
Selling General and Administrative
68,078
79,467
87,648
82,196
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
92,251
109,445
126,455
111,392
Operating Income or Loss
(16,658)
55,775
117,155
177,314
Income from Continuing Operations
Total Other Income/Expenses Net
(232,362)
(37,558)
(378,776)
(40,587)
Earnings Before Interest And Taxes
(249,020)
18,217
(261,621)
136,727
Interest Expense
53,830
66,845
84,624
85,634
Income Before Tax
(302,850)
(48,628)
(346,245)
51,093
Income Tax Expense
60,625
(15,262)
(74,138)
22,403
Minority Interest
--
--
--
0
Net Income From Continuing Ops
(363,475)
(33,366)
(272,107)
28,690
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(363,475)
(33,366)
(272,107)
28,690
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(363,475)
(33,366)
(272,107)
28,690